Steve Aldington

Retinal Research and Professional Development Manager

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Steve Aldington is the Retinal Research and Professional Development Manager at Gloucestershire Hospitals NHS Foundation Trust in the UK. His research primarily focuses on diabetic eye disease, with recent publications including studies on multimodal imaging and the evaluation of new screening pathways for diabetic retinopathy. Dr. Aldington also investigates innovative care models for patients with complications related to diabetic eye conditions, contributing significantly to the field through his work on both artificial intelligence and cost analysis in healthcare settings.

Articles (12)

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Ariel Wang

University of Oxford

UNITED KINGDOM

View details

Simon Harding

Chair Professor of Ophthalmology

University of Liverpool

UNITED KINGDOM

View details

Massimo Porta

University of Turin

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Steve Aldington

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

The Scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 1

The scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 2

Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy

Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study

Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study

Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: The emerald diagnostic accuracy study

Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study (vol 128, pg 561, 2021)

Reply.

The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial

Evaluation of a new model of care for people with complications of diabetic retinopathy: The EMERALD Study

Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients.

The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial

Collaborators (3)

Ariel Wang

Simon Harding

Massimo Porta

Make your next move.